.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
US Department of Justice
Harvard Business School
Farmers Insurance
Cerilliant
Queensland Health
McKinsey
Express Scripts
Chinese Patent Office
Moodys

Generated: November 19, 2017

DrugPatentWatch Database Preview

Beclomethasone dipropionate - Generic Drug Details

« Back to Dashboard

What are the generic sources for beclomethasone dipropionate and what is the scope of beclomethasone dipropionate patent protection?

Beclomethasone dipropionate
is the generic ingredient in eleven branded drugs marketed by Teva Branded Pharm, Norton Waterford, Schering, and Glaxosmithkline, and is included in eleven NDAs. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Beclomethasone dipropionate has two hundred and thirty-six patent family members in thirty countries.

There are twenty drug master file entries for beclomethasone dipropionate. Four suppliers are listed for this compound.

Pharmacology for beclomethasone dipropionate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering
VANCENASE AQ
beclomethasone dipropionate monohydrate
SPRAY, METERED;NASAL020469-001Jun 26, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Norton Waterford
QVAR REDIHALER
beclomethasone dipropionate
AEROSOL, METERED;INHALATION207921-002Aug 3, 2017RXYesYes► Subscribe► SubscribeY ► Subscribe
Teva Branded Pharm
QVAR 80
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911-001Sep 15, 2000RXYesYes► Subscribe► SubscribeY ► Subscribe
Schering
VANCERIL
beclomethasone dipropionate
AEROSOL, METERED;INHALATION017573-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
BECONASE
beclomethasone dipropionate
AEROSOL, METERED;NASAL018584-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Schering
VANCENASE
beclomethasone dipropionate
AEROSOL, METERED;NASAL018521-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Branded Pharm
QVAR 40
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911-002Sep 15, 2000RXYesYes► Subscribe► SubscribeY ► Subscribe
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813-002Dec 17, 2014RXYesNo► Subscribe► Subscribe► Subscribe
Norton Waterford
QVAR REDIHALER
beclomethasone dipropionate
AEROSOL, METERED;INHALATION207921-001Aug 3, 2017RXYesNo► Subscribe► SubscribeY ► Subscribe
Norton Waterford
QVAR REDIHALER
beclomethasone dipropionate
AEROSOL, METERED;INHALATION207921-001Aug 3, 2017RXYesNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: beclomethasone dipropionate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering
VANCENASE
beclomethasone dipropionate
AEROSOL, METERED;NASAL018521-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Glaxosmithkline
BECONASE
beclomethasone dipropionate
AEROSOL, METERED;NASAL018584-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Schering
VANCENASE
beclomethasone dipropionate
AEROSOL, METERED;NASAL018521-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Teva Branded Pharm
QVAR 40
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911-002Sep 15, 2000► Subscribe► Subscribe
Teva Branded Pharm
QVAR 40
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911-002Sep 15, 2000► Subscribe► Subscribe
Teva Branded Pharm
QVAR 80
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911-001Sep 15, 2000► Subscribe► Subscribe
Glaxosmithkline
BECLOVENT
beclomethasone dipropionate
AEROSOL, METERED;INHALATION018153-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813-002Dec 17, 2014► Subscribe► Subscribe
Schering
VANCERIL
beclomethasone dipropionate
AEROSOL, METERED;INHALATION017573-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Schering
VANCERIL
beclomethasone dipropionate
AEROSOL, METERED;INHALATION017573-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: beclomethasone dipropionate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,533,111Dose counters for inhalers, inhalers and methods of assembly thereof► Subscribe
6,553,988 Medicament dispensing device with a multimaterial diaphragm bounding a pneumatic force chamber► Subscribe
8,978,966Dose counters for inhalers, inhalers and methods of assembly thereof► Subscribe
9,216,260Dose counters for inhalers, inhalers and methods of assembly thereof► Subscribe
8,225,780Medicament dispensing device with a multimaterial diaphragm bounding a pneumatic force chamber► Subscribe
9,526,851Dose counters for inhalers, inhalers and methods of assembly thereof► Subscribe
9,174,013Dose counters for inhalers, inhalers and methods of assembly thereof► Subscribe
9,731,087Dose counter for inhaler having a bore and shaft arrangement► Subscribe
9,108,010Dose counters for inhalers, inhalers and methods of assembly thereof► Subscribe
9,526,850Dose counters for inhalers, inhalers and methods of assembly thereof► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: beclomethasone dipropionate

Country Document Number Estimated Expiration
South Korea101559643► Subscribe
Hong Kong1223312► Subscribe
World Intellectual Property Organization (WIPO)2005113044► Subscribe
Mexico2011012755► Subscribe
Hong Kong1201766► Subscribe
South Korea20130103825► Subscribe
South Korea101618931► Subscribe
South Korea101628934► Subscribe
Canada2887315► Subscribe
Japan2014144352► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Fish and Richardson
Novartis
Deloitte
Fuji
Mallinckrodt
Express Scripts
Farmers Insurance
Healthtrust
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot